Brokerages Set Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Price Target at $32.29
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) has received an average recommendation of “Buy” from the eight research firms that are covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 month […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) has received an average recommendation of “Buy” from the eight research firms that are covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 month […]
